Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

1.48
Delayed Data
As of Oct 16
 0.00 / 0.00%
Today’s Change
0.70
Today|||52-Week Range
19.80
-66.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues3.3M3.1M3.5M3.9M
 
 
 
 
 
Cost of Goods Sold1.7M1.6M1.6M1.7M
 
 
 
 
 
Depreciation And Amortization1.1M993.0K972.0K965.0K
 
 
 
 
 
 
Operating ExpensesGross Income500.0K486.0K886.0K1.2M
 
 
 
 
 
General Expenses4.8M4.4M1.5M4.8M
 
 
 
 
 
Research And Development659.0K308.0K306.0K413.0K
 
 
 
 
 
Total Operating Expenses7.6M7.1M4.0M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-3.9M-578.0K-3.6M
 
 
 
 
 
Extraordinary Credit1.2M10.7M5.8M0.00
 
 
 
 
Extraordinary Charge-3.4M0.00-3.0M-2.7M
 
 
 
 
Interest Expense On Debt539.0K544.0K254.0K216.0K
 
 
 
 
 
Other Expenses4.0K0.00-36.0K-8.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M6.2M1.9M-6.6M
 
 
 
 
 
Income Taxes-173.0K-108.0K-3.0K-301.0K
 
 
 
 
 
Discontinued Operations-297.0K-23.0K556.0K-54.0K
 
 
 
 
 
Net Income-7.5M6.3M2.4M-6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.8M1.9M4.3M9.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M1.9M4.4M9.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.10$3.24$0.55-$0.65
 
 
 
 
 
EPS Diluted-$4.13$3.24$0.55-$0.65